Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Hyperfine (HYPR)
NASDAQ:HYPR
Holding HYPR?
Track your performance easily
Earnings Data
Report Date
Mar 19, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
-$0.14Last Year’s EPS
-$0.15Same Quarter Last Year
Based on 1 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 12, 2024
|% Change Since: -4.94%
|Next Earnings Date:Mar 19, 2025
Earnings Call Sentiment|Positive
The earnings call presented a strong performance with significant revenue growth, gross margin expansion, and successful international expansion. However, the company still faces challenges with net losses and cash burn. The overall sentiment is positive, driven by technological advancements, clinical study successes, and strategic market expansion.Company Guidance
During the Q3 2024 earnings call for Hyperfine, executives provided guidance and shared several key metrics. The company reported a revenue of $3.6 million, marking a 56% year-over-year growth, and achieved a gross margin of 52%, which reflects over 270 basis points of sequential expansion. For the full year 2024, Hyperfine narrowed its revenue outlook to a range of $14 million to $14.5 million, expecting approximately 30% year-over-year growth. The gross margin for 2024 is anticipated to range between 47% and 50%. Despite a net loss of $10.3 million, equivalent to $0.14 per share, the company highlighted successful expense management and cost-saving initiatives that have contributed to a reduction in cash burn, expected to be between $37 million and $40 million for the year. The company is confident in surpassing a 50% gross margin sustainably, driven by strategic expansion and technological advancements.Strong Revenue Growth
Hyperfine reported revenue of $3.6 million for Q3 2024, representing a 56% year-over-year growth. Year-to-date revenue is $10.6 million, up 27% from the first 9 months of 2023.
Gross Margin Expansion
The company achieved a gross margin of 52% for Q3 2024, a record level, with year-to-date gross margin at 48%, representing over 330 basis points of expansion from the first 9 months of 2023.
FDA Clearance for AI-Powered Software
Hyperfine received FDA clearance for its ninth generation AI-powered software, which improves image quality and reduces acquisition times.
International Expansion
Hyperfine expanded its distribution network in the European markets and obtained CE approval for its latest generation software.
Promising Clinical Study Results
The Swoop system showed promising results in detecting ARIA complications and acute stroke diagnosis, supporting its use in Alzheimer's and stroke care.
---
HYPR Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
HYPR Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 12, 2024 | $0.93 | $0.86 | -7.53% |
| Aug 08, 2024 | $1.10 | $1.13 | +2.73% |
| May 13, 2024 | $0.80 | $0.88 | +10.00% |
| Mar 21, 2024 | $1.13 | $1.01 | -10.62% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Hyperfine (HYPR) report earnings?
Hyperfine (HYPR) is schdueled to report earning on Mar 19, 2025, TBA Not Confirmed.
What is Hyperfine (HYPR) earnings time?
Hyperfine (HYPR) earnings time is at Mar 19, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is HYPR EPS forecast?
HYPR EPS forecast for the fiscal quarter 2024 (Q4) is -$0.14.
---